These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 34142298

  • 1. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
    Abdelhady EI, Rabie M, Hassan RA.
    Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
    [Abstract] [Full Text] [Related]

  • 2. Definition of low disease activity state based on the SLE-DAS: derivation and validation in a multicentre real-life cohort.
    Assunção H, Jesus D, Larosa M, Henriques C, Matos A, Le Guern V, Rubiño F, da Silva JAP, Rua-Figueroa I, Costedoat-Chalumeau N, Doria A, Inês LS.
    Rheumatology (Oxford); 2022 Aug 03; 61(8):3309-3316. PubMed ID: 34864894
    [Abstract] [Full Text] [Related]

  • 3. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
    Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration.
    Ann Rheum Dis; 2016 Sep 03; 75(9):1615-21. PubMed ID: 26458737
    [Abstract] [Full Text] [Related]

  • 4. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
    Lai NS, Lu MC, Chang HH, Lo HC, Hsu CW, Huang KY, Tung CH, Hsu BB, Wu CH, Koo M.
    J Clin Med; 2021 May 15; 10(10):. PubMed ID: 34063379
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study.
    Golder V, Huq M, Franklyn K, Calderone A, Lateef A, Lau CS, Lee ALH, Navarra STV, Godfrey T, Oon S, Hoi AYB, Morand EF, Nikpour M.
    Semin Arthritis Rheum; 2017 Jun 15; 46(6):798-803. PubMed ID: 28216192
    [Abstract] [Full Text] [Related]

  • 7. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
    Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L, Da Silva JAP, Doria A, Inês LS.
    Ann Rheum Dis; 2019 Mar 15; 78(3):365-371. PubMed ID: 30626657
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up.
    Cunha RN, Saraiva L, Jesus D, Doria A, da Silva JP, Inês LS.
    Rheumatology (Oxford); 2023 Nov 02; 62(11):3627-3635. PubMed ID: 36847423
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus.
    Na Nakorn K, Piyaphanee N, Sukharomana M, Pinpatanapong R, Charuvanij S.
    Clin Rheumatol; 2023 Jun 02; 42(6):1655-1664. PubMed ID: 36780064
    [Abstract] [Full Text] [Related]

  • 11. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
    Chitpet P, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P, Leosuthamas P, Pakchotanon R.
    Int J Rheum Dis; 2023 Dec 02; 26(12):2509-2516. PubMed ID: 37875327
    [Abstract] [Full Text] [Related]

  • 12. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort.
    Altabás-González I, Rúa-Figueroa I, Rubiño F, Mouriño Rodríguez C, Hernández-Rodríguez I, Menor Almagro R, Uriarte Isacelaya E, Tomero Muriel E, Salman-Monte TC, Carrión-Barberà I, Galindo M, Rodríguez Almaraz EM, Jiménez N, Inês L, Pego-Reigosa JM.
    Rheumatology (Oxford); 2023 Mar 01; 62(3):1162-1169. PubMed ID: 35961050
    [Abstract] [Full Text] [Related]

  • 13. Association of disease activity with depression and anxiety in systemic lupus erythematosus: A comparison of SLEDAI-2K and SLE-DAS.
    Yang L, Gu B, Wang X, Ren Q, Shen M, Su D.
    Rheumatology (Oxford); 2024 Feb 01. PubMed ID: 38305645
    [Abstract] [Full Text] [Related]

  • 14. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
    Pawlak-Buś K, Schmidt W, Leszczyński P.
    Eur Rev Med Pharmacol Sci; 2023 Feb 01; 27(3):949-959. PubMed ID: 36808341
    [Abstract] [Full Text] [Related]

  • 15. Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
    Elefante E, Tani C, Stagnaro C, Signorini V, Parma A, Carli L, Zucchi D, Ferro F, Mosca M.
    Arthritis Res Ther; 2020 Oct 14; 22(1):241. PubMed ID: 33054823
    [Abstract] [Full Text] [Related]

  • 16. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
    Cho J, Shen L, Huq M, Kandane-Rathnayake R, Golder V, Louthrenoo W, Chen YH, Hamijoyo L, Luo SF, Wu YJ, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Navarra SV, Lau CS, Hoi A, Morand EF, Nikpour M, Lateef A, Asia-Pacific Lupus Collaboration.
    Lancet Rheumatol; 2023 Oct 14; 5(10):e584-e593. PubMed ID: 38251484
    [Abstract] [Full Text] [Related]

  • 17. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
    Ma J, Zhang L, Yan M, Liu Z, Xue L.
    Lupus Sci Med; 2024 Jun 10; 11(1):. PubMed ID: 38862157
    [Abstract] [Full Text] [Related]

  • 18. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
    Onishi A, Tsuji H, Takase Y, Nakakubo Y, Iwasaki T, Kozuki T, Yoshida T, Shirakashi M, Onizawa H, Hiwa R, Kitagori K, Akizuki S, Nakashima R, Yoshifuji H, Tanaka M, Morinobu A.
    Rheumatology (Oxford); 2023 Dec 01; 62(12):3909-3915. PubMed ID: 36943365
    [Abstract] [Full Text] [Related]

  • 19. Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus.
    Yeo AL, Koelmeyer R, Kandane-Rathnayake R, Golder V, Hoi A, Huq M, Hammond E, Nab H, Nikpour M, Morand EF.
    Arthritis Care Res (Hoboken); 2020 Sep 01; 72(9):1289-1295. PubMed ID: 31282076
    [Abstract] [Full Text] [Related]

  • 20. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
    Kikuchi J, Hanaoka H, Saito S, Oshige T, Hiramoto K, Kaneko Y, Takeuchi T.
    Rheumatology (Oxford); 2022 Aug 30; 61(9):3777-3791. PubMed ID: 35015824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.